EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Metabolic-Associated Fatty Liver Disease

Kirthika Venkatesan, Nisha Nigil Haroon

Endocrinology and Metabolism Clinics of North America · 2023

DOI: 10.1016/j.ecl.2023.02.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2023. Verfasst von Kirthika Venkatesan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Caribbean Medical University School of Medicine, 25 Pater Euwensweg, Willemstad, Curaçao; Walden University, 650 South Exerter Street, Baltimore, MD …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Cardiovascular Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-associated fatty liver disease (MAFLD), previously known as nonalcoholic fatty liver disease (NAFLD), is the most common cause of liver disease in the world. Its prevalence is over 30% and is becoming the most common cause of liver transplants. Rates are rising along with obesity-related diseases. Risk factors for MAFLD include adverse lifestyles, genetic variations, advancing age, male sex, and alterations in the gut microbiota. Extrahepatic complications include cardiovascular disease, renal dysfunction, and colorectal cancer. As there are no currently approved medications for MAFLD, management mainly focuses on lifestyle modifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCardiovascular DiseasesHumansMaleRisk FactorsBehavior TherapyLife Style

Stichwörter der Autor:innen

Bariatric proceduresLifestyle modificationsMetabolic-associated fatty liver diseaseNonalcoholic fatty liver diseaseNonalcoholic steatohepatitisPharmacotherapy

Autor:innen und Institutionen

  • Caribbean Medical University School of Medicine, 25 Pater Euwensweg, Willemstad, Curaçao; Walden University, 650 South Exerter Street, Baltimore, MD 21202, USA.
  • Clinical Sciences Division, Northern Ontario School of Medicine, Sudbury, Ontario, Canada; Health Sciences North Research Institute, Sudbury, Ontario, Canada. Electronic address: nnigilharoon@hsnsudbury.ca.

Zitieren

APA

Venkatesan, K., & Haroon, N. N. (2023). Management of Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America. https://doi.org/10.1016/j.ecl.2023.02.002

Vancouver

Venkatesan K, Haroon NN. Management of Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America. 2023. doi:10.1016/j.ecl.2023.02.002

BibTeX
@article{Venkatesan2023,
  author = {Venkatesan, Kirthika and Haroon, Nisha Nigil},
  title = {Management of Metabolic-Associated Fatty Liver Disease},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2023},
  doi = {10.1016/j.ecl.2023.02.002}
}
Kostenlos starten →